Doriemus plc, which has oil interests in the Weald in southern England, has replaced its chairman.
The company said in a statement today that David Lenigas had resigned “effective immediately”. He has been replaced by Keith Coughlan.
Mr Lenigas has been a director of Doriemus since June 2016. He was previously a director of UKOG companies. He tweeted today that he was focusing on medical cannabis.
Mr Coughlan is currently managing director of European Metals Holdings Limited, non-executive director of Calidus Resources Ltd and Southern Hemisphere Mining Limited. The statement he had almost 30 years experience in stockbroking and funds management.
Doriemus has a 4% interest in Horse Hill Developments Ltd, the operator of the Horse Hill licence near Gatwick Airport. The company also has a 10% interest in the Brockham licence near Dorking and 5% in PEDL331 around Arreton on the Isle of Wight.
In April 2019, Doriemus sold its interest in Lidsey, near Bognor Regis in West Sussex, to the operator, Angus Energy.
Categories: Industry
DRILL OR DROP? 
Smart move.
So medical cannabis is more lucrative than oil?
Par for the course with Lenigas, get in, get discounted shares, pump the SP, sell at a profit, then leave mug investors paying the price.
Definitely, PaulaC.
Mind you, getting the GP to prescribe is not so easy, whilst they will prescribe flying off to a bit of sun, aided by that nasty old oil.
Vets seem more willing to prescribe for dogs. But, you can get a blood test result within 10 minutes for dogs as well.
Funny old world.